A leap towards personalised therapy of acute lung injury. | Eur Respir J;60(6)2022 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

A leap towards personalised therapy of acute lung injury.

Witzenrath, Martin; Welte, Tobias.

Witzenrath M; Charité-Universitätsmedizin Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany martin.witzenrath@charite.de.
Welte T; German Center for Lung Research (DZL).

Eur Respir J ; 60(6)2022 12.

Article in English | MEDLINE | ID: covidwho-2196002

Subject(s)

Acute Lung Injury; COVID-19; Humans; Imatinib Mesylate; Acute Lung Injury/therapy; Precision Medicine; Immunomodulation

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Lung Injury / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.01808-2022

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Lung Injury / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.01808-2022